Clinical Trial Update: Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pipamperone/citalopram combination to citalopram alone and to pipamperone alone in major depressive disorder has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Citalopram (CIT) (citalopram)
• Pipamperone (PIP) (pipamperone)
• Pipamperone/Citalopram (PNB01)

Snippet

Sponsor: PharmaNeuroBoost N.V. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2022-04-07